Hypothesis
Osteosarcoma is a serious and aggressive bone cancer that mostly affects large, older dogs. It causes painful swelling and weakens the bone, often leading to fractures. Standard treatment usually involves removing the affected limb and giving chemotherapy, but sadly, fewer than half of dogs survive beyond a year after diagnosis.
Researchers believe that the immune system may play a key role in helping dogs live longer with this disease. Specifically, they are investigating whether dogs (and children) who have immune cells inside their bone tumors survive longer than those whose immune cells stay outside the tumors. This idea is based on early observations and could lead to a major shift in how we understand and treat bone cancer in dogs.
Research Approach
To test this idea, scientists at the University of Minnesota funded by the AKC Canine Health Foundation (CHF) are using advanced DNA technology to study the types and locations of immune cells within bone tumors. This research, 03015: The Immune and Molecular Landscape of Canine Osteosarcoma at the Single-Cell Level, looks at the tumor at the single-cell level, which means they’re examining each cell individually to understand how the immune system interacts with the cancer.
Another CHF-funded study, 03032-MOU: Early Detection of Canine Osteosarcoma, is working on a blood test that could detect bone cancer in dogs much earlier—before it becomes a full-blown tumor. This could help vets catch the disease sooner and possibly prevent it from developing at all.
Veterinary students like Caitlyn Callaghan and Courtney Labé are actively involved in these projects. They’re learning how to process samples, observe clinical cases, and contribute to research that could change the future of canine cancer care. Their work is guided by experienced researchers like Dr. Julia Medland and Dr. Jaime Modiano, who are committed to training the next generation of veterinary oncologists.
Potential Impact
These studies could lead to major breakthroughs in how we treat and even prevent bone cancer in dogs. If researchers can confirm that certain immune cells inside tumors help dogs live longer, future treatments might focus on boosting those specific immune responses. This could mean more effective therapies with fewer side effects than traditional chemotherapy.
The early detection study could be a game-changer for dog owners. Imagine a simple blood test that helps catch bone cancer before your dog shows any symptoms. That kind of early warning could give vets a better chance to stop the disease in its tracks.
Beyond helping dogs, this research may also benefit children with osteosarcoma, since the disease behaves similarly in both species. By studying dogs, scientists can learn more about the human version of the disease too.
Dr. Modiano emphasizes that the strength of these projects comes from the diversity and dedication of the team—including students, technicians, and dog-loving donors. Their shared goal is to reduce the number of dogs affected by bone cancer and improve the quality of life for those who are. To learn more about CHF-funded cancer research and educational grants, visit akcchf.org/research.
